Loading
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Latest filing published 29 Sept 2026 for Precision Biosciences INC, €6,253.
Filing timeline
BuySaleMelinda Brown
Insider track record
Disclosed buys
6
Disclosed sells
1
Signal history
Closed purchases
Market purchases
6
Positive at T+90
60%
Median T+90
+20.5%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +55.5%Entry US$4.52 · Close at T+90 US$7.03
- +26.2%Entry US$4.93 · Close at T+365 US$6.22
- +88.6%Entry US$4.20 · Close at T+365 US$7.92
- +13.6%Entry US$4.77 · Close at T+365 US$5.42
- +9.2%Entry US$3.81 · Close at T+365 US$4.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Melinda Brown: trading record in brief
Six purchases out of seven open-market trades: purchases are 86% of what Melinda Brown filed, nearly all of them recent and small. They are worth EUR 45,155 in total, with a median of EUR 6,107, and sit at Precision Biosciences Inc (Director): EUR 13,196 on December 26, 2024, EUR 8,098 on March 26, 2025 and EUR 6,253 on September 25, 2026. The single sale, EUR 284,402, is dated September 12, 2017 at Tapestry, Inc., where the title is SVP, Controller and PAO.
The 21 filings, published between November 8, 2016 and September 29, 2026, split between Tapestry (12) and Precision Biosciences (9). They include 9 share grants, 3 option exercises and 2 filings of another kind. The pace has had two phases, 2016 to 2018 (up to 7 in 2018), then 2024 to 2026 (up to 5 in 2025). Three filings, two of them purchases, fall in the last twelve months.
Brown has 4, 3 and 3 own market trades within 30 days of colleagues at Precision Biosciences Inc, in that order. Every one in the same direction. Names in order: Geno J. Germano, Kevin Buehler and Stanley Frankel.
Companies and markets linked to Melinda Brown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
1,135 shares@ US$6.270.0033% mcap13.8% of flowCommon StockSEC:0001628280-26-063767:0
Canonical exit: 24 Dec 2026 (T+90)
21,000 sharesCommon StockSEC:0001628280-26-037536:0
1,381 shares@ US$4.9715.0% of flowCommon StockSEC:0001628280-25-057482:0
Canonical exit: 15 Mar 2026 (T+90)
1,400 shares@ US$4.8914.9% of flowCommon StockSEC:0001628280-25-042524:0
Canonical exit: 21 Dec 2025 (T+90)
1,682 shares@ US$4.1415.3% of flowCommon StockSEC:0001628280-25-033200:0
Canonical exit: 23 Sept 2025 (T+90)
9,826 sharesCommon StockSEC:0000950170-25-081724:0
1,839 shares@ US$4.7520.8% of flowCommon StockSEC:0000950170-25-046332:0
Canonical exit: 24 Jun 2025 (T+90)
3,016 shares@ US$4.5533.9% of flowCommon StockSEC:0000950170-24-140921:0
Canonical exit: 26 Mar 2025 (T+90)
4,202 sharesCommon StockSEC:0000950170-24-054576:0
780 shares@ US$51.415.8% of flowCommon StockSEC:0001225208-18-012779:0
2,823 shares0Common StockSEC:0001225208-18-012578:0
959 shares@ US$47.466.6% of flowCommon StockSEC:0001225208-18-012578:1
5,145 shares@ US$47.4635.3% of flowCommon StockSEC:0001225208-18-012578:2
2,624 shares@ US$47.9318.0% of flowCommon StockSEC:0001225208-18-012514:0
947 shares@ US$47.922.8% of flowCommon StockSEC:0001225208-18-006047:0
3,979 shares@ US$52.5912.4% of flowCommon StockSEC:0001225208-18-006047:1
8,250 shares@ US$41.2820.7% of flowCommon StockSEC:0001225208-17-015002:0
6,179 shares@ US$41.0015.8% of flowCommon StockSEC:0001225208-17-014179:0
1,007 shares@ US$47.923.0% of flowCommon StockSEC:0001225208-17-014104:1
2,723 shares0Common StockSEC:0001225208-17-014104:0
6,913 shares@ US$35.7216.2% of flowCommon StockSEC:0001225208-16-041323:0
21 of 21 declarations
